Lymphopenia News and Research

RSS
Lymphopenia is a condition in which there is a lower-than-normal number of lymphocytes (a type of white blood cell) in the blood. Also called lymphocytic leukopenia and lymphocytopenia.
First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

New combination therapy for cancer cells could soon be a reality

New combination therapy for cancer cells could soon be a reality

FDA approves first therapy for patients with rare tumors of the adrenal gland

FDA approves first therapy for patients with rare tumors of the adrenal gland

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Scientists discover how gene mutation affects T cell function to promote immune disorders

Scientists discover how gene mutation affects T cell function to promote immune disorders

FDA approves new radioactive drug for treatment of rare digestive tract cancers

FDA approves new radioactive drug for treatment of rare digestive tract cancers

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Research finds new therapeutic strategy to prevent infections in spinal cord injury patients

Research finds new therapeutic strategy to prevent infections in spinal cord injury patients

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Vaccine-chemotherapy combination may improve survival for glioblastoma patients

Vaccine-chemotherapy combination may improve survival for glioblastoma patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Lenalidomide trials show potential for expanding lymphoma, leukaemia indications

Lenalidomide trials show potential for expanding lymphoma, leukaemia indications

FDA grants accelerated approval for Darzalex to treat patients with multiple myeloma

FDA grants accelerated approval for Darzalex to treat patients with multiple myeloma